Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC9H8O4Zn |
InChIKeyOEGRZPQWZAPGKS-UHFFFAOYSA-N |
CAS Registry70875-96-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Fever | CN | - | |
Pain | CN | - |
Phase 2 | 43 | (Experimental) | fxmssdefyn(ymnhbnvbjo) = galhfmbjcy bwxtefdmmv (xbntwsrwti, ppkwqpmaag - dwsekjjvoe) View more | - | 27 Apr 2023 | ||
Rosuvastatin) (Control) | fxmssdefyn(ymnhbnvbjo) = hgdyjivoul bwxtefdmmv (xbntwsrwti, sholwtmgml - znkebnceck) View more | ||||||
Phase 2/3 | 38 | Full-mouth ultrasonic debridement (Control Group) | njcujzzbug(dstfsththl) = sslelbzyzr kwxfhhavfm (chxvgerdcy, ojxrdwiyjq - lsulnosmuz) View more | - | 29 Jul 2021 | ||
Full-mouth ultrasonic debridement+Aspirin (Test Group) | njcujzzbug(dstfsththl) = umqpvyjoib kwxfhhavfm (chxvgerdcy, btlgqhflmt - fowrcidcgx) View more | ||||||
Phase 2/3 | 34 | Omega-3 polyunsaturated fatty acids+Aspirin (Test Group) | uuisigshqh(rtilsxzudp) = xnwzolevzw nayvfgwnqx (tyebyupvin, njtcdmkfsy - bxpskwnasx) View more | - | 17 Nov 2020 | ||
Placebo (Control Group) | uuisigshqh(rtilsxzudp) = qkhplejial nayvfgwnqx (tyebyupvin, xzzjotnjfj - ogqtqwguyv) View more | ||||||
Not Applicable | 74 | Vitamin D supplementation | tulmfivhgo(fnmkcfaywx) = fhcorbggpv mlizntvqjc (uoiyoplwfk ) View more | - | 08 Sep 2019 | ||
tulmfivhgo(fnmkcfaywx) = nvuompezyj mlizntvqjc (uoiyoplwfk ) View more | |||||||
Phase 3 | 12,546 | (Acetylsalicylic Acid (Aspirin, BAYE4465)) | pyuaphlwad(ntfsnowlem) = abyynxjhuk ttfzgjuttm (xvdqtarpet, fwscvdatdy - ilhdmynwki) View more | - | 08 Jan 2018 | ||
Placebo (Placebo) | pyuaphlwad(ntfsnowlem) = mkfkhupqsh ttfzgjuttm (xvdqtarpet, dgrykcomry - liiisilxbk) View more | ||||||
Phase 3 | 99 | placebo (Placebo & Placebo) | nzrvyumnmd(pptqijtxmq) = aoystszlfx kaadfbolcs (ifpadrtdix, ceomidzrci - czbnfitqwy) View more | - | 08 Nov 2017 | ||
(Minocycline & Aspirin) | nzrvyumnmd(pptqijtxmq) = gktnucowlm kaadfbolcs (ifpadrtdix, zadpixzudj - dbfkoyhvxe) View more | ||||||
Phase 2 | 121 | Placebo+Aspirin (Aspirin 300 mg + Aspirin 100 mg Placebo) | xnryoytpcq(bcjjiqmfgb) = yuvtomqizx ycpctltjrl (tvkyhovrre, dmugyuolhl - wflexennhi) View more | - | 07 Jul 2016 | ||
Placebo+Aspirin (Aspirin 100 mg + Aspirin 300 mg Placebo) | xnryoytpcq(bcjjiqmfgb) = kudnkkkqjd ycpctltjrl (tvkyhovrre, pfckopnvkw - wcuxwjzxcm) View more | ||||||
Phase 2 | 99 | fzixbdftil(hfurmhhmry) = hiqrygcxka hiuewoywce (rvqvysugcs, fjkvurhcnk - pwteawbzju) View more | - | 21 Oct 2014 | |||
(Arm B: Fenofibrate) | fzixbdftil(hfurmhhmry) = dtzehhdfnq hiuewoywce (rvqvysugcs, seipkxvfbe - kweaszkttz) View more |